Suppr超能文献

微小RNA-139-5p通过下调自噬膜相关蛋白受体(AMFR)和Notch1抑制结肠直肠癌的迁移和侵袭。

MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1.

作者信息

Song Mingxu, Yin Yuan, Zhang Jiwei, Zhang Binbin, Bian Zehua, Quan Chao, Zhou Leyuan, Hu Yaling, Wang Qifeng, Ni Shujuan, Fei Bojian, Wang Weili, Du Xiang, Hua Dong, Huang Zhaohui

机构信息

Wuxi Oncology Institute, the Affiliated Hospital of Jiangnan University, Wuxi, 214062, China.

出版信息

Protein Cell. 2014 Nov;5(11):851-61. doi: 10.1007/s13238-014-0093-5. Epub 2014 Aug 23.

Abstract

MicroRNAs (miRNAs) that exert function by posttranscriptional suppression have recently brought insight in our understanding of the role of non-protein-coding RNAs in carcinogenesis and metastasis. In this study, we described the function and molecular mechanism of miR-139-5p in colorectal cancer (CRC) and its potential clinical application in CRC. We found that miR-139-5p was significantly downregulated in 73.8% CRC samples compared with adjacent noncancerous tissues (NCTs), and decreased miR-139-5p was associated with poor prognosis. Functional analyses demonstrated that ectopic expression of miR-139-5p suppressed CRC cell migration and invasion in vitro and metastasis in vivo. Mechanistic investigations revealed that miR-139-5p suppress CRC cell invasion and metastasis by targeting AMFR and NOTCH1. Knockdown of the two genes phenocopied the inhibitory effect of miR-139-5p on CRC metastasis. Furthermore, the protein levels of the two genes were upregulated in CRC samples compared with NCTs, and inversely correlated with the miR-139-5p expression. Increased NOTCH1 protein expression was correlated with poor prognosis of CRC patients. Together, our data indicate that miR-139-5p is a potential tumor suppressor and prognostic factor for CRC, and targeting miR-139-5p may repress the metastasis of CRC and improve survival.

摘要

通过转录后抑制发挥功能的微小RNA(miRNA)最近使我们对非蛋白质编码RNA在癌症发生和转移中的作用有了更深入的了解。在本研究中,我们描述了miR-139-5p在结直肠癌(CRC)中的功能和分子机制及其在CRC中的潜在临床应用。我们发现,与相邻的非癌组织(NCT)相比,73.8%的CRC样本中miR-139-5p显著下调,且miR-139-5p降低与预后不良相关。功能分析表明,miR-139-5p的异位表达在体外抑制CRC细胞迁移和侵袭,在体内抑制转移。机制研究显示,miR-139-5p通过靶向AMFR和NOTCH1抑制CRC细胞侵袭和转移。敲低这两个基因可模拟miR-139-5p对CRC转移的抑制作用。此外,与NCT相比,CRC样本中这两个基因的蛋白水平上调,且与miR-139-5p表达呈负相关。NOTCH1蛋白表达增加与CRC患者预后不良相关。总之,我们的数据表明,miR-139-5p是CRC的潜在肿瘤抑制因子和预后因素,靶向miR-139-5p可能抑制CRC转移并改善生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f192/4235840/f6bcaac6fa32/13238_2014_93_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验